Hernández-Quero J - Search Results

1

Predicting antiretroviral drug resistance from the latest or the cumulative genotype.

Garcia F, Alvarez M, Fox Z, Garcia-Diaz A, Guillot V, Johnson M, Chueca N, Phillips A, Hernández-Quero J, Geretti AM. Garcia F, et al. Antivir Ther. 2011;16(3):373-82. doi: 10.3851/IMP1753. Antivir Ther. 2011. PMID: 21555820

2

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.

Macías J, Mira JA, López-Cortés LF, Santos I, Girón-González JA, González-Serrano M, Merino D, Hernández-Quero J, Rivero A, Merchante N, Trastoy M, Carrillo-Gómez R, Arizcorreta-Yarza A, Gómez-Mateos J, Pineda JA. Macías J, et al. Antivir Ther. 2006;11(7):839-46. Antivir Ther. 2006. PMID: 17302246

3

[Genotypic resistance in HIV-1-infected patients with persistent low-level viremia].

Parra-Ruiz J, Alvarez M, Chueca N, Peña A, Pasquau J, López-Ruz MA, Maroto Mdel C, Hernández-Quero J, García F. Parra-Ruiz J, et al. Enferm Infecc Microbiol Clin. 2009 Feb;27(2):75-80. doi: 10.1016/j.eimc.2008.02.007. Epub 2009 Feb 13. Enferm Infecc Microbiol Clin. 2009. PMID: 19254638 Spanish.

4

Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools.

Chueca N, Garrido C, Alvarez M, Poveda E, de Dios Luna J, Zahonero N, Hernández-Quero J, Soriano V, Maroto C, de Mendoza C, García F. Chueca N, et al. J Med Virol. 2009 May;81(5):763-7. doi: 10.1002/jmv.21425. J Med Virol. 2009. PMID: 19319937

5

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists.

Poveda E, Alcamí J, Paredes R, Córdoba J, Gutiérrez F, Llibre JM, Delgado R, Pulido F, Iribarren JA, García Deltoro M, Hernández Quero J, Moreno S, García F. Poveda E, et al. AIDS Rev. 2010 Jul-Sep;12(3):135-48. AIDS Rev. 2010. PMID: 20842202 Review.

6

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A; Cohort of the Spanish AIDS Research Network (CoRIS). Yebra G, et al. J Clin Microbiol. 2012 Feb;50(2):407-13. doi: 10.1128/JCM.05798-11. Epub 2011 Dec 7. J Clin Microbiol. 2012. PMID: 22162552 Free PMC article.

7

Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists.

Poveda E, Paredes R, Moreno S, Alcamí J, Córdoba J, Delgado R, Gutiérrez F, Llibre JM, García Deltoro M, Hernández-Quero J, Pulido F, Iribarren JA, García F. Poveda E, et al. AIDS Rev. 2012 Jul-Sep;14(3):208-17. AIDS Rev. 2012. PMID: 22833064 Review.

8

Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter.

Álvarez Estévez M, Chueca Porcuna N, Guillot Suay V, Peña Monge A, García García F, Muñoz Medina L, Vinuesa García D, Parra Ruiz J, Hernández-Quero J, García García F. Álvarez Estévez M, et al. J Clin Microbiol. 2013 May;51(5):1555-7. doi: 10.1128/JCM.00100-13. Epub 2013 Feb 6. J Clin Microbiol. 2013. PMID: 23390288 Free PMC article.

9

[Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance].

Chueca Porcuna N, Alvarez Estévez M, Parra Ruiz J, Hernández Quero J, García García F. Chueca Porcuna N, et al. Enferm Infecc Microbiol Clin. 2013 Feb;31 Suppl 1:40-7. doi: 10.1016/S0213-005X(13)70113-7. Enferm Infecc Microbiol Clin. 2013. PMID: 23453230 Spanish.

10

Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects.

Genebat M, Vera F, Hernández-Quero J, Domingo P, Guardiola JM, Martínez-Madrid O, Martínez L, de la Llana FG, Sánchez-Villegas J, Alvarez H, Mariño A, Lluch JF, Martínez-Pérez MA, Marín J, Ruiz-Mateos E, Leal M. Genebat M, et al. Antiviral Res. 2014 Apr;104:59-61. doi: 10.1016/j.antiviral.2014.01.019. Epub 2014 Jan 31. Antiviral Res. 2014. PMID: 24491797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page